Changes in Beneficial Ownership · 4
CapsoVision, Inc.
CVNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
primary_doc.xml
Filing details
- Report period
- 2026-09-18
- Issuer
- CapsoVision, Inc
- Issuer CIK
- 0001378325
- Trading symbol
- CV
Reporting owner 1
- Name
- HARARI ELIYAHOU ET AL
- Reporting owner CIK
- 0001009165
- Relationship
- 10% owner
- Address
- 2290 NORTH 1ST STREET, SUITE 102, SAN JOSE, CA, 95131
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | 2026-09-18 | P · Form 4 | 878,735 | A | 5.69 | 1,396,494 | I | By trust.[F1] |
| Common Stock | 2026-09-18 | P · Form 4 | 878,734 | A | 5.69 | 878,734 | I | By trust.[F2] |
Table key
- P · Form 4
- Purchase on the market or privately
- A
- Acquired
- I
- Indirect
Footnotes
Signature 1
- Signed
- /s/ Peter Bergman, Attorney-in-Fact for Eliyahou Harari
- Date
- 2026-09-23
Company context
We are a global commercial-stage medical technology company focused on creating diagnostic and screening products to identify abnormalities of the GI tract. We develop advanced imaging and AI technologies in creating such products while maximizing the flexibility, convenience, profitability, and safety of patient care. We are a Delaware company, incorporated in 2005. Our corporate headquarters is located in Saratoga, California.